Refine Search

  •  
  •  
Big Movers in the Stock Market

...improve survival for a form of lung cancer. The drug has been licensed by Genentech and Roche Holding AG of Switzerland. Abgenix Inc. up $3.00 at $17.70 Investors interpreted the good news for Tarceva as boosting prospects for this biotech's...

http://chronicle.augusta.com/stories/2004/04/27/fin_413588.shtml
Finance
1